أخبار

BEIJING, AUGUST 24, 2021 - Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu Medical”), a leading global company specialized in developing, manufacturing and marketing high-tech medical devices and equipment, today announced that its حقنة معقمة لخط الاستخدام الواحد حاصل على موافقة علامة CE للاستخدام العام ، بما في ذلك توصيل لقاحات مختلفة.

تشير علامة CE إلى أن حقنة Lepu الطبية المعقمة للاستخدام الفردي تلبي معايير فئة الاتحاد الأوروبي للسلامة والأداء للاستخدام من قبل المتخصصين في الرعاية الصحية لأغراض عامة شفط السوائل والحقن ، مما يجعلها متاحة للشراء الاحترافي جميع أنحاء الاتحاد الأوروبي والبلدان الأخرى التي تعترف بعلامة CE.

Lepu Medical’s حقنة معقمة لخط الاستخدام الواحد has received CE Mark approval at a time of high-demand for needles suitable to vaccinate populations against the COVID-19 pandemic.  Lepu Medical’s syringe series offers a variety of single-use needles for many applications, including various COVID-19 vaccines. The line includes both Luer Lock and Lock Slip syringes, a clear barrel, plunger, plunger stopper, needle, and cap. Lepu Medical’s syringe series offers a higher resistance to breakage in single-use, and latex-free pistons. The total graduated capacity of all models of syringes is 1mL, with a range of needle sizes to meet a variety of injection and COVID-19 vaccine needs, each distinguished by the color of the needle hub.

Designed to meet a variety of injection needs, Lepu Medical’s Sterile Syringe For Single-Use brings improved safety to patients and doctors with its clear barrel for convenient control of foreign substances. The Sterile Syringe For Single-Use is intended only for one-time use by  healthcare professionals who have received training on medical injection techniques. Injection and vaccine administrators can refer to the Lepu Medical professional manual before use for a full understanding of the device instructions, warnings and precautions.

بالإضافة إلى الحقنة المعقمة للاستخدام الفردي ، قدمت Lepu مستلزمات طبية مختلفة للوقاية والتحكم بما في ذلك مجموعة الاختبار السريع للمستضد للاختبار الذاتي ومجموعة اختبار الأجسام المضادة للاختبار الاحترافي للرعاية الصحية. كما يقدم الليبو حلول تشخيصية مثل منتجات وحلول الحمض النووي لتوفير اختبارات قياسية للتشخيص ، ومنتجات اختبار الأجسام المضادة لمراقبة مستويات المناعة. تشمل منتجات وحلول Lepu Medical الأخرى مجموعات جمع العينات ، ومجموعات استخراج العينات اليدوية ، ومستخلصات العينات الآلية وأنظمة PCR في الوقت الفعلي لتشخيص الحمض النووي السريري القياسي.

As of August 2021, the number of global daily doses of COVID-19 vaccines continues to rise, driving demand for vaccines and vaccination supplies. According to published statistics, by the end of 2020, major governments had placed purchases for over nine billion vaccine units. With the onset of the Delta virus, vaccination rates are ramping up and the expected number of vaccine units is increasing. Government officials and medical professionals across the globe from Israel, France, Germany, the U.S, the United Arab Emirates, Bahrain, the United Kingdom, Switzerland, Cambodia and others are proposing and actively preparing for the third dose of the COVID-19 vaccination to strengthen pandemic prevention and control efforts. With the CE Mark approval for the Sterile Syringe For Single-Use, Lepu Medical will continue to proactively seek qualified partners to support the availability of reliable vaccine supplies across the globe, and assist with COVID-19 management and continuation of general medical practices.